Vivitrol 380 MG vial-diluents
Ended Awarded
- Contract number
- SPE2DB25FQ65W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,845
Award facts
- Contract value 100% obligated
- $8,844.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials and diluents, with a ceiling value of $8,844.95. This is a firm fixed price, non-set-aside contract awarded on September 9, 2025, with an ultimate completion date of September 10, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical support to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, has demonstrated extensive capability in supplying a diverse range of pharmaceutical products and medical supplies to Department of Defense and related government healthcare systems through competitive procurement. Vivitrol (naltrexone for extended-release injectable suspension) is an FDA-approved medication used in the treatment of opioid use disorder and alcohol dependence, representing the type of specialized pharmaceutical product that AmerisourceBergen routinely delivers through its federal contracts. The company's proven track record of fulfilling federal medical supply requirements across multiple therapeutic domains, combined with its position as a prime vendor under DLA's pharmaceutical support program, positions it as a key supplier for military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FQ65W?
SPE2DB25FQ65W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FQ65W worth?
The government has obligated $8,845 on SPE2DB25FQ65W.
Is contract SPE2DB25FQ65W an order under another contract?
Yes. SPE2DB25FQ65W is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQ65W competed?
The extent of competition for SPE2DB25FQ65W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award